Physician profile
Seth Cohen
NPI 1164670287
$12,340.32
in general payments reported to CMS, 2019-2025
16 companies · $3,453 in 2025
The $3,453 reported for 2025 was more than what 79% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $3,213 · 2021: $216 · 2022: $254 · 2023: $636 · 2024: $3,790 · 2025: $3,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,250 · Food and Beverage: $1,247 · Consulting Fee: $963 · Travel and Lodging: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,250.00 |
| Food and Beverage | $1,247.42 |
| Consulting Fee | $962.50 |
| Travel and Lodging | $419.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,796.40 | 2019-2025 | |
| Abbvie INC. | $1,004.47 | 2022-2025 | Botox |
| Medtronic, INC. | $801.43 | 2021-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $409.36 | 2019-2020 | |
| Urogen Pharma, INC. | $405.53 | 2022-2025 | Jelmyto |
| Coloplast Corp | $299.90 | 2019-2021 | |
| Boston Scientific Corporation | $178.59 | 2019-2023 | |
| Laborie Medical Technologies Corp. | $112.10 | 2019 | |
| Astellas Pharma US INC | $85.46 | 2019-2021 | |
| Axonics, INC. | $85.27 | 2024 | Bulkamid |
| Abbott Laboratories | $46.32 | 2025 | Proclaim |
| Allergan, INC. | $24.86 | 2019 | |
| Caldera Medical, INC | $24.50 | 2022 | |
| Glaxosmithkline, LLC. | $24.49 | 2024 | Zejula, Jemperli |
| Emd Serono, INC. | $23.02 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.